$CERS
CERUS CORP Stock $cers

$cers Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000119312514403411 Filed on November 07, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$9.587M	$10.36M	$10.54M
YoY Change	3.85%	-1.71%	27.75%
Cost Of Revenue	$6.590M	$5.689M	$6.826M
YoY Change	33.43%	-16.66%	54.75%
Gross Profit	$2.997M	$4.673M	$3.716M
YoY Change	-30.19%	25.75%	-3.25%
Gross Profit Margin	31.26%	45.1%	35.25%
Selling, General & Admin	$10.69M	$8.724M	$7.728M
YoY Change	43.88%	12.89%	24.26%
% of Gross Profit	356.69%	186.69%	207.97%
Research & Development	$5.190M	$7.250M	$4.363M
YoY Change	12.39%	66.17%	129.27%
% of Gross Profit	173.17%	155.15%	117.41%
Depreciation & Amortization	$430.0K	$370.0K	$130.0K
YoY Change	26.47%	184.62%	-27.78%
% of Gross Profit	14.35%	7.92%	3.5%
Operating Expenses	$15.93M	$16.02M	$12.14M
YoY Change	31.66%	31.98%	48.57%
Operating Profit	-$12.93M	-$11.35M	-$8.425M
YoY Change	65.68%	34.73%	94.53%
Interest Expense	-$6.910M	$249.0K	$41.00K
YoY Change	-483.89%	507.32%	-69.85%
% of Operating Profit
Other Income/Expense, Net	-$240.0K	$600.0K	-$12.02M
YoY Change	-112.01%	-104.99%	-1397.62%
Pretax Income	-$20.08M	-$10.75M	-$20.44M
YoY Change	245.79%	-47.4%	500.32%
Income Tax	$110.0K	$8.000K	$60.00K
% Of Pretax Income
Net Earnings	-$20.18M	-$10.76M	-$20.50M
YoY Change	244.4%	-47.52%	492.51%
Net Earnings / Revenue	-210.51%	-103.83%	-194.47%
Basic Earnings Per Share	-$0.26	-$0.14	-$0.29
Diluted Earnings Per Share	-$0.26	-$0.16	-$0.29
COMMON SHARES
Basic Shares Outstanding	78.27M shares	75.19M shares	69.79M shares
Diluted Shares Outstanding		76.10M shares	69.79M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.29M	$47.60M	$53.30M
YoY Change	-11.1%	-10.69%	99.63%
Cash & Equivalents	$22.78M	$22.34M	$24.36M
Short-Term Investments	$28.51M	$25.20M	$29.00M
Other Short-Term Assets	$1.932M	$2.429M	$394.0K
YoY Change	337.1%	516.5%	-87.69%
Inventory	$14.96M	$13.50M	$12.69M
Prepaid Expenses	$1.210M	$1.780M	$1.071M
Receivables	$5.493M	$7.366M	$7.025M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$74.89M	$72.65M	$74.50M
YoY Change	-4.18%	-2.48%	71.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.781M	$3.882M	$1.848M
YoY Change	72.73%	110.06%	2.67%
Goodwill	$1.316M	$1.316M	$1.316M
YoY Change	0.0%	0.0%
Intangibles	$1.142M	$1.193M	$1.395M
YoY Change	-15.03%	-14.48%
Long-Term Investments
YoY Change
Other Assets	$144.0K	$51.00K	$72.00K
YoY Change	105.71%	-29.17%	-82.0%
Total Long-Term Assets	$6.891M	$6.743M	$4.937M
YoY Change	31.83%	36.58%	-5.06%
TOTAL ASSETS
Total Short-Term Assets	$74.89M	$72.65M	$74.50M
Total Long-Term Assets	$6.891M	$6.743M	$4.937M
Total Assets	$81.78M	$79.40M	$79.44M
YoY Change	-1.92%	-0.06%	63.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.882M	$4.115M	$4.076M
YoY Change	74.16%	0.96%	-28.49%
Accrued Expenses	$8.444M	$12.55M	$12.06M
YoY Change	-13.95%	4.04%	48.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$3.600M
YoY Change	-100.0%	-100.0%	-26.53%
Total Short-Term Liabilities	$29.19M	$21.15M	$42.59M
YoY Change	-25.97%	-50.33%	56.01%
LONG-TERM LIABILITIES
Long-Term Debt	$9.900M	$9.900M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$1.081M	$998.0K	$1.120M
YoY Change	0.75%	-10.89%	1.82%
Total Long-Term Liabilities	$1.081M	$998.0K	$1.120M
YoY Change	0.75%	-10.89%	-74.55%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.19M	$21.15M	$42.59M
Total Long-Term Liabilities	$1.081M	$998.0K	$1.120M
Total Liabilities	$40.26M	$32.12M	$43.79M
YoY Change	-0.82%	-26.66%	38.15%
SHAREHOLDERS EQUITY
Retained Earnings	-$541.9M	-$521.8M	-$497.3M
YoY Change	7.7%	4.91%
Common Stock	$583.5M	$77.00K	$70.00K
YoY Change	6.87%	10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.52M	$47.28M	$35.65M
YoY Change
Total Liabilities & Shareholders Equity	$81.78M	$79.40M	$79.44M
YoY Change	-1.92%	-0.06%	63.12%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$20.18M	-$10.76M	-$20.50M
YoY Change	244.4%	-47.52%	492.51%
Depreciation, Depletion And Amortization	$430.0K	$370.0K	$130.0K
YoY Change	26.47%	184.62%	-27.78%
Cash From Operating Activities	-$8.630M	-$11.74M	-$6.090M
YoY Change	32.16%	92.78%	248.0%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$600.0K	-$260.0K
YoY Change	-63.64%	130.77%	550.0%
Acquisitions
YoY Change
Other Investing Activities	-$3.790M	-$4.260M	-$29.17M
YoY Change	-683.08%	-85.4%
Cash From Investing Activities	-$3.870M	-$4.860M	-$29.43M
YoY Change	-1000.0%	-83.49%	73475.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.93M	10.38M	1.670M
YoY Change	15.14%	521.56%	-6.7%
NET CHANGE
Cash From Operating Activities	-8.630M	-11.74M	-6.090M
Cash From Investing Activities	-3.870M	-4.860M	-29.43M
Cash From Financing Activities	12.93M	10.38M	1.670M
Net Change In Cash	430.0K	-6.220M	-33.85M
YoY Change	-91.62%	-81.62%	3606440755835040000.0%
FREE CASH FLOW
Cash From Operating Activities	-$8.630M	-$11.74M	-$6.090M
Capital Expenditures	-$80.00K	-$600.0K	-$260.0K
Free Cash Flow	-$8.550M	-$11.14M	-$5.830M
YoY Change	35.5%	91.08%	240.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24355000
CY2013Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	0
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.08
CY2014Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17600000	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11998000	shares
CY2014Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	9860000
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2314000
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3227000
CY2014Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	100000
CY2014Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3931000
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	21153000
CY2014Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	-11000
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	77000
CY2014Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11000
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4115000
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-521762000
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	3227000
CY2014Q3	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	3931000
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	108000
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12547000
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	47276000
CY2014Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	998000
CY2014Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2053000
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3227000
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79395000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	824000
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	568972000
CY2014Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2928000
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	174000
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3931000
CY2014Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	560000
CY2014Q3	us-gaap	Liabilities Liabilities	32119000
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2956000
CY2014Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	0
CY2014Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	695000
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	12864000
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22343000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	200000
CY2014Q3	us-gaap	Goodwill Goodwill	1316000
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3882000
CY2014Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	31427000
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	31416000
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	301000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1193000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	200000
CY2014Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11149000
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	29396000
CY2014Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1800000
CY2014Q3	us-gaap	Cost Method Investments CostMethodInvestments	0
CY2014Q3	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	13503000
CY2014Q3	us-gaap	Assets Assets	79395000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	200000
CY2014Q3	us-gaap	Inventory Net InventoryNet	13503000
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7366000
CY2014Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31427000
CY2014Q3	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	25231000
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1193000
CY2014Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2429000
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51000
CY2014Q3	us-gaap	Assets Current AssetsCurrent	72652000
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	29389000
CY2014Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	31416000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	50000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000
CY2014Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2014Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2354000
CY2014Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1780000
CY2014Q3	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	10000000
CY2014Q3	cers	Outstanding Liability Related To Leasehold Improvements Current And Non Current OutstandingLiabilityRelatedToLeaseholdImprovementsCurrentAndNonCurrent	600000
CY2014Q3	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	140000
CY2014Q3	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	2027000
CY2014Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	200000
CY2014Q3	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	4	Customer
CY2014Q3	cers	Accrued Inventory AccruedInventory	4610000
CY2014Q3	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2014Q3	cers	Leasehold Improvement Reflected In Other Non Current Liabilities LeaseholdImprovementReflectedInOtherNonCurrentLiabilities	500000
CY2014Q3	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	0
CY2014Q3	cers	Finite Lived Intangible Assets Amortization Expense Year Seven FiniteLivedIntangibleAssetsAmortizationExpenseYearSeven	100000
CY2014Q3	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	2031000
CY2014Q3	cers	Leasehold Improvement Reflected In Accrued Liabilities LeaseholdImprovementReflectedInAccruedLiabilities	100000
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	78269402	shares
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26696000
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.46
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10405000	shares
CY2013Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	0
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	400000
CY2013Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	20390000
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	39424000
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	7000
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	72000
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	7000
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5674000
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-503189000
CY2013Q4	us-gaap	Fair Value Liabilities Measured On Recurring Basis Obligations FairValueLiabilitiesMeasuredOnRecurringBasisObligations	20390000
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	89000
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9813000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	42795000
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1073000
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1011000
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83381000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	673000
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	545905000
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2722000
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	20390000
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	181000
CY2013Q4	us-gaap	Liabilities Liabilities	40586000
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2527000
CY2013Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	3366000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29485000
CY2013Q4	us-gaap	Goodwill Goodwill	1316000
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2189000
CY2013Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	36834000
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	36841000
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	308000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1344000
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8200000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	30700000
CY2013Q4	us-gaap	Inventory Finished Goods And Work In Process Net Of Reserves InventoryFinishedGoodsAndWorkInProcessNetOfReserves	13063000
CY2013Q4	us-gaap	Assets Assets	83381000
CY2013Q4	us-gaap	Inventory Net InventoryNet	13063000
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6125000
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	36834000
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28191000
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1344000
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	442000
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000
CY2013Q4	us-gaap	Assets Current AssetsCurrent	78154000
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	30701000
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	36841000
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2017000
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4863000
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	848000
CY2013Q4	cers	Debt Instrument Carrying Non Current DebtInstrumentCarryingNonCurrent	0
CY2013Q4	cers	Debt Instrument Unamortized Noncurrent DebtInstrumentUnamortizedNoncurrent	0
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue	6140000
CY2013Q4	cers	Cumulative Outstanding Trade Receivables Number Of Major Customers CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers	2	Customer
CY2013Q4	cers	Accrued Inventory AccruedInventory	3553000
CY2013Q4	cers	Debt Instrument Unamortized Current DebtInstrumentUnamortizedCurrent	0
CY2013Q4	cers	Debt Instrument Carrying Current DebtInstrumentCarryingCurrent	3366000
CY2013Q4	cers	Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost	6134000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2014Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
	cers	Agreement Expiration Date AgreementExpirationDate	2014-09-30
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-20133000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66464000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16301000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66464000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-37477000
	us-gaap	Gross Profit GrossProfit	12762000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	30425000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	29162000
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	16800000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-154000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1345000
	us-gaap	Payments For Royalties PaymentsForRoyalties	2300000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20493000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-96000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	198000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37510000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16819000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-37312000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	14000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65000
	us-gaap	Dilutive Securities DilutiveSecurities	0
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	6176000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	440000
	us-gaap	Net Income Loss NetIncomeLoss	-37477000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2581000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-33000
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2415000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	20000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	410000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	34000
	us-gaap	Interest Expense InterestExpense	279000
	us-gaap	Operating Expenses OperatingExpenses	33255000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22535000
	us-gaap	Other Noncash Expense OtherNoncashExpense	0
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2341000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	16803000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	165000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	17663000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	47408000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50981000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4448000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-29616000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	595000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10569000
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3110000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2008000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0
	us-gaap	Share Based Compensation ShareBasedCompensation	2415000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	11800000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.41
	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	CERUS CORP
	dei	Trading Symbol TradingSymbol	CERS
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2030000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	40000	shares
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-31177000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	134000	shares
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2734000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 14pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 4pt; TEXT-INDENT: 8%" align="justify">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, which are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p> </div>
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001020214
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.61
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.77
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75437000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 24pt"> <b>Guarantee and Indemnification Arrangements</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 4pt; TEXT-INDENT: 8%" align="justify">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company’s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company’s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 10pt; TEXT-INDENT: 8%" align="justify">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable.</p> </div>
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.93
	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	13900000
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11737000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 14pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 4pt; TEXT-INDENT: 8%" align="justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, short-term investments and accounts receivable.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 10pt; TEXT-INDENT: 8%" align="justify">Pursuant to the Company’s investment policy, substantially all of the Company’s cash, cash equivalents and short-term investments are maintained at a major financial institution of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company’s investments carry high credit quality ratings, which is in accordance with its investment policy. At September 30, 2014, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company’s cash equivalents and short-term investments.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 10pt; TEXT-INDENT: 8%" align="justify">Concentrations of credit risk with respect to trade receivables exist. However, for certain customers, the Company purchases a credit insurance policy that mitigates some of its credit risk, as the policy will pay either the Company or its lender on eligible claims filed on its outstanding receivables. On a regular basis, including at the time of sale, the Company performs credit evaluations of significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company reserves against the accounts receivable on its condensed consolidated balance sheets and records a charge on its condensed consolidated statements of operations. At September 30, 2014 and December 31, 2013, the Company had not recorded any reserves for potentially uncollectible accounts.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 10pt; TEXT-INDENT: 8%" align="justify">The Company had four and two customers that accounted for more than 10% of the Company’s outstanding trade receivables at each of September 30, 2014 and December 31, 2013, respectively. These customers cumulatively represented approximately 77% and 55% of the Company’s outstanding trade receivables, at September 30, 2014 and December 31, 2013, respectively. To date, the Company has not experienced collection difficulties from these customers.</p> </div>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	967000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73407000	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-32836000
	us-gaap	Gross Profit GrossProfit	12231000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	26829000
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	14807000
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	6000000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2860000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	632000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-14263000
	us-gaap	Payments For Royalties PaymentsForRoyalties	1900000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-31574000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3000
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-945000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-18591000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	13091000
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18483000
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-50000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	449000
	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
	us-gaap	Dilutive Securities DilutiveSecurities	-14263000
	us-gaap	Repayments Of Long Term Debt And Capital Securities RepaymentsOfLongTermDebtAndCapitalSecurities	3446000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2033000
	us-gaap	Net Income Loss NetIncomeLoss	-18573000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1241000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-18000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3764000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	19000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	989000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	379000
	us-gaap	Interest Expense InterestExpense	676000
	us-gaap	Operating Expenses OperatingExpenses	43805000
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	3000000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27040000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	2196000
	us-gaap	Other Noncash Expense OtherNoncashExpense	65000
	cers	Safety Product Warranty Period SafetyProductWarrantyPeriod	P1Y
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	151000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7142000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-14263000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	90000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14598000
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	23520000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6849000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2728000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	515000
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10269000
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	16614000
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1555000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9848000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17305000
	us-gaap	Share Based Compensation ShareBasedCompensation	3764000
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	cers	Expiration Of Non Cancelable Operating Leases Maximum Year ExpirationOfNonCancelableOperatingLeasesMaximumYear	2019
	cers	Inventory Life Finished Goods Period InventoryLifeFinishedGoodsPeriod	P2Y
	cers	Work In Process Inventory Life Period WorkInProcessInventoryLifePeriod	P1Y
	cers	Eligible To Receive Royalty Fee EligibleToReceiveRoyaltyFee	0.01	pure
	cers	Prior Written Notice Period For Termination Of Agreement PriorWrittenNoticePeriodForTerminationOfAgreement	P24M
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2013Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	12416000
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000
	cers	Minimum Term Of Non Cancelable Operating Leases MinimumTermOfNonCancelableOperatingLeases	P1Y
	cers	Sales Commissions And Fees Per Unit SalesCommissionsAndFeesPerUnit	10
CY2010	cers	Proceeds From Landlord Financing Leasehold Improvement ProceedsFromLandlordFinancingLeaseholdImprovement	1100000
CY2013	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	12000000
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69791000	shares
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2013Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16651000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69791000	shares
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-20501000
CY2013Q3	us-gaap	Gross Profit GrossProfit	3716000
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10542000
CY2013Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	800000
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8425000
CY2013Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	409000
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20534000
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-12016000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20441000
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	32000
CY2013Q3	us-gaap	Dilutive Securities DilutiveSecurities	0
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-20501000
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-33000
CY2013Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	861000
CY2013Q3	us-gaap	Interest Expense InterestExpense	41000
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	12141000
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7728000
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6826000
CY2013Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4363000
CY2013Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2013Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2013Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4200000
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	909000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	76103000	shares
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12032000	shares
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	10362000
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75194000	shares
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12497000
CY2014Q3	us-gaap	Gross Profit GrossProfit	4673000
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11351000
CY2014Q3	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	2200000
CY2014Q3	us-gaap	Payments For Royalties PaymentsForRoyalties	600000
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-941000
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10776000
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	600000
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10751000
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	145000
CY2014Q3	us-gaap	Goodwill Other Changes GoodwillOtherChanges	0
CY2014Q3	us-gaap	Dilutive Securities DilutiveSecurities	-1738000
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-10759000
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17000
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1478000
CY2014Q3	us-gaap	Interest Expense InterestExpense	342000
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	16024000
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8724000
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50000
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1738000
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5689000
CY2014Q3	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	7250000
CY2014Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2014Q3	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2014Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2014Q3	cers	Payment For Manufacturing Of Entity Products PaymentForManufacturingOfEntityProducts	4300000
CY2014Q3	cers	Number Of Disposable Kits NumberOfDisposableKits	2000	Disposable_Kits

Files In Submission

Name	View Source	Status
0001193125-14-403411-index-headers.html	Edgar Link	pending
0001193125-14-403411-index.html	Edgar Link	pending
0001193125-14-403411.txt	Edgar Link	pending
0001193125-14-403411-xbrl.zip	Edgar Link	pending
cers-20140930.xml	Edgar Link	completed
cers-20140930.xsd	Edgar Link	pending
cers-20140930_cal.xml	Edgar Link	unprocessable
cers-20140930_def.xml	Edgar Link	unprocessable
cers-20140930_lab.xml	Edgar Link	unprocessable
cers-20140930_pre.xml	Edgar Link	unprocessable
d792781d10q.htm	Edgar Link	pending
d792781dex311.htm	Edgar Link	pending
d792781dex312.htm	Edgar Link	pending
d792781dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CERS
CERUS CORP Stock $cers

2014 Q4 Form 10-Q Financial Statement

#000119312514403411 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS CERUS CORP Stock $cers

2014 Q4 Form 10-Q Financial Statement

#000119312514403411 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CERS
CERUS CORP Stock $cers